Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 13, 1997

View Archived Issues

British Biotech: Q1 1997 highlights

Yoshitomi licenses immunosuppressant to Novartis

Cambridge NeuroScience awarded sixteenth SBIR grant

Improved efficacy of MEN-10755 related to apoptosis?

NIH approves study of marijuana in HIV-infected patients

GM-237354: a new antifungal sordarin derivative from Glaxo Wellcome

KBT-3022: pharmacokinetics and pharmacological effects in guinea pigs

Vanguard Medica and Abbott collaborate on development of new oral asthma therapy

Alza, Alkermes to codevelop RMP-7 for brain-specific drug delivery

Phase II results for IDEC-C2B8 in NHL

CV Therapeutics moves ranolazine to phase III

Combined pharmacological/genetic strategy for HIV shows promise

Gonal-F approved for marketing in U.S.

Antiproliferative activity of simvastatin demonstrated against human gliomas

Mutual Recognition Procedure concludes for Nasonex

DCLHb evaluated in critically ill patients

Oral desmopressin evaluated in bed-wetting children

Eltenac efficacy demonstrated in osteoarthritis

NIH grant to support development of CytRx's Protox

Preclinical data indicate effectiveness of Sertoli cells in neural regeneration

CellPro seeks new indication for CEPRATE SC System

FDA actively reviewing TOBI

Bacterial and viral infections focus of ArQule-RiboGene collaboration

Cancer cells being used to treat cancer

Briana Bio-Tech licenses peptide technology for chronic MS

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...